Physicians have launched the world’s first mRNA lung cancer vaccine trial, marking a significant advancement in cancer treatment.
BioNTech developed the vaccine BNT116, which targets non-small cell lung cancer (NSCLC) by training the immune system to identify and attack tumor markers.
Conducted across seven countries, including Türkiye, the phase 1 trial involves 130 patients with varying stages of lung cancer and aims to eliminate cancer cells and prevent recurrence.
The trial uses mRNA technology similar to that in COVID-19 vaccines, potentially offering a less toxic alternative to traditional chemotherapy.
Experts view this trial as a groundbreaking step in cancer research, with the first patient in the UK receiving the vaccine recently.
Source : PhilNews24 | August 24, 2024
WORLD’S INITIAL LUNG CANCER VACCINE TRIAL KICKS OFF
Latest from News
The PNP, BJMP, and BFP have backed proposals to raise the compulsory retirement age of their
The Bureau of Immigration and the Civil Aviation Authority of the Philippines will deploy additional personnel
The Department of Public Works and Highways (DPWH) is accelerating the construction and repair of a
The Manila Police District announced that several roads, including Blumentritt Road, Dimasalang and Maceda Streets, and
The Department of Transportation (DOTr) said 100 local and international companies have expressed interest in investing